Go Pro

GENinCode (GENI) Competitors

GENinCode logo
GBX 0.80 -0.08 (-8.57%)
As of 07/24/2026 11:54 AM Eastern

GENI vs. AMC, DIS, LION, SPHR, and GVC

Should you buy GENinCode stock or one of its competitors? MarketBeat compares GENinCode with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GENinCode include Amur Minerals (AMC), Distil (DIS), Lionsgold (LION), Sphere Medical (SPHR), and Entain PLC (GVC.L) (GVC). These companies are all part of the "entertainment" industry.

How does GENinCode compare to Amur Minerals?

GENinCode (LON:GENI) and Amur Minerals (LON:AMC) are both small-cap entertainment companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Amur Minerals has lower revenue, but higher earnings than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GENinCode£3.08M1.96-£6.10M-£2.08N/A
Amur MineralsN/AN/A-£2.39MN/AN/A

Amur Minerals has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Amur Minerals' return on equity of -14.97% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
GENinCode-185.47% -409.40% -63.99%
Amur Minerals N/A -14.97%-7.77%

11.4% of GENinCode shares are owned by institutional investors. 8.4% of GENinCode shares are owned by insiders. Comparatively, 1.5% of Amur Minerals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, GENinCode's average media sentiment score of 0.00 equaled Amur Minerals'average media sentiment score.

Company Overall Sentiment
GENinCode Neutral
Amur Minerals Neutral

GENinCode has a beta of 0.593, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Amur Minerals has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

Summary

GENinCode beats Amur Minerals on 5 of the 9 factors compared between the two stocks.

How does GENinCode compare to Distil?

Distil (LON:DIS) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

0.0% of Distil shares are held by institutional investors. Comparatively, 11.4% of GENinCode shares are held by institutional investors. 22.8% of Distil shares are held by insiders. Comparatively, 8.4% of GENinCode shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Distil has a net margin of -126.58% compared to GENinCode's net margin of -185.47%. Distil's return on equity of -21.81% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Distil-126.58% -21.81% -7.50%
GENinCode -185.47%-409.40%-63.99%

Distil has a beta of 0.894, indicating that its share price is 11% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.593, indicating that its share price is 41% less volatile than the broader market.

Distil has higher earnings, but lower revenue than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Distil£963K1.42-£2.19M-£0.08N/A
GENinCode£3.08M1.96-£6.10M-£2.08N/A

In the previous week, Distil's average media sentiment score of 0.00 equaled GENinCode'saverage media sentiment score.

Company Overall Sentiment
Distil Neutral
GENinCode Neutral

Summary

Distil beats GENinCode on 7 of the 11 factors compared between the two stocks.

How does GENinCode compare to Lionsgold?

GENinCode (LON:GENI) and Lionsgold (LON:LION) are both entertainment companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

11.4% of GENinCode shares are owned by institutional investors. 8.4% of GENinCode shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Lionsgold has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Lionsgold's return on equity of 0.00% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
GENinCode-185.47% -409.40% -63.99%
Lionsgold N/A N/A N/A

In the previous week, GENinCode's average media sentiment score of 0.00 equaled Lionsgold'saverage media sentiment score.

Company Overall Sentiment
GENinCode Neutral
Lionsgold Neutral

Lionsgold has lower revenue, but higher earnings than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GENinCode£3.08M1.96-£6.10M-£2.08N/A
LionsgoldN/AN/AN/AN/AN/A

Summary

GENinCode and Lionsgold tied by winning 3 of the 6 factors compared between the two stocks.

How does GENinCode compare to Sphere Medical?

Sphere Medical (LON:SPHR) and GENinCode (LON:GENI) are both entertainment companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

In the previous week, Sphere Medical's average media sentiment score of 0.00 equaled GENinCode'saverage media sentiment score.

Company Overall Sentiment
Sphere Medical Neutral
GENinCode Neutral

Sphere Medical has higher earnings, but lower revenue than GENinCode.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sphere MedicalN/AN/AN/AN/AN/A
GENinCode£3.08M1.96-£6.10M-£2.08N/A

11.4% of GENinCode shares are held by institutional investors. 8.4% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sphere Medical has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Sphere Medical's return on equity of 0.00% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Sphere MedicalN/A N/A N/A
GENinCode -185.47%-409.40%-63.99%

Summary

Sphere Medical and GENinCode tied by winning 3 of the 6 factors compared between the two stocks.

How does GENinCode compare to Entain PLC (GVC.L)?

Entain PLC (GVC.L) (LON:GVC) and GENinCode (LON:GENI) are both entertainment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

In the previous week, Entain PLC (GVC.L)'s average media sentiment score of 0.00 equaled GENinCode'saverage media sentiment score.

Company Overall Sentiment
Entain PLC (GVC.L) Neutral
GENinCode Neutral

11.4% of GENinCode shares are held by institutional investors. 8.4% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Entain PLC (GVC.L) has higher revenue and earnings than GENinCode. GENinCode is trading at a lower price-to-earnings ratio than Entain PLC (GVC.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Entain PLC (GVC.L)£3.40B0.00N/A-£26.80N/A
GENinCode£3.08M1.96-£6.10M-£2.08N/A

Entain PLC (GVC.L) has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Entain PLC (GVC.L)'s return on equity of 0.00% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Entain PLC (GVC.L)N/A N/A N/A
GENinCode -185.47%-409.40%-63.99%

Summary

Entain PLC (GVC.L) and GENinCode tied by winning 4 of the 8 factors compared between the two stocks.

Get GENinCode News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GENI vs. The Competition

MetricGENinCodeDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£6.02M£652.87M£7.06B£2.58B
Dividend YieldN/A3.33%2.67%6.17%
P/E Ratio-0.3869.3027.14368.39
Price / Sales1.96572.97582.3084,422.84
Price / Cash0.8311.4249.8127.89
Price / Book0.493.0710.287.41
Net Income-£6.10M£334.07B£3.60B£5.89B
7 Day Performance-1.84%-0.51%-1.27%0.39%
1 Month Performance-14.89%-0.30%-1.67%0.27%
1 Year Performance-53.62%5.83%18.25%68.12%

GENinCode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GENI
GENinCode
N/AGBX 0.80
-8.6%
N/A-53.6%£6.02M£3.08MN/A2,300
AMC
Amur Minerals
N/AN/AN/AN/A£1.25MN/AN/A33,700
DIS
Distil
N/AGBX 0.05
-16.9%
N/A-59.6%£1.10M£963KN/A220,000
LION
Lionsgold
N/AN/AN/AN/A£0.00N/AN/A2,021
SPHR
Sphere Medical
N/AN/AN/AN/A£0.00N/AN/A10,900

Related Companies and Tools


This page (LON:GENI) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners